Production (Stage)
Spectral Medical Inc.
EDT.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.57M | 1.67M | 1.48M | 1.40M | 1.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.57M | 1.67M | 1.48M | 1.40M | 1.29M |
| Cost of Revenue | 905.10K | 995.80K | 957.40K | 945.00K | 870.60K |
| Gross Profit | 666.50K | 672.80K | 518.80K | 459.10K | 417.00K |
| SG&A Expenses | 9.71M | 8.78M | 9.00M | 8.91M | 8.76M |
| Depreciation & Amortization | 519.60K | 570.40K | 555.40K | 551.00K | 226.50K |
| Other Operating Expenses | 189.20K | 139.20K | 129.70K | 248.80K | 210.80K |
| Total Operating Expenses | 11.32M | 10.48M | 10.64M | 10.66M | 10.07M |
| Operating Income | -9.75M | -8.81M | -9.16M | -9.25M | -8.78M |
| Income Before Tax | -17.07M | -11.37M | -18.37M | -13.78M | -13.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.07 | -11.37 | -18.37 | -13.78 | -13.75 |
| Earnings from Discontinued Operations | -5.00K | -5.10K | -24.30K | -121.20K | -84.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.08M | -11.38M | -18.39M | -13.90M | -13.84M |
| EBIT | -9.75M | -8.81M | -9.16M | -9.25M | -8.78M |
| EBITDA | -9.66M | -8.72M | -9.09M | -9.17M | -8.70M |
| EPS Basic | -0.06 | -0.04 | -0.07 | -0.05 | -0.05 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 |
| EPS Diluted | -0.06 | -0.04 | -0.07 | -0.05 | -0.05 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 1.13B | 1.12B | 1.12B | 1.12B | 1.12B |
| Average Diluted Shares Outstanding | 1.13B | 1.12B | 1.12B | 1.12B | 1.12B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |